Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Family of heart patient who died awarded $45M after suing health system for negligence
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
FDA clears catheter-based 4D visualization platform for complex heart procedures
The new technology from LUMA Vision allows operators to deliver 2D and 4D ultrasound images in real time. The advanced catheter was built with maneuverability and increased visibility in mind.

MRI technique helps establish new biomarker for minor stroke

Using dynamic contrast-enhanced MRI, researchers found quantitatively mapping a patient’s blood-brain barrier dysfunction (BBBD) may be valuable for risk stratification and stroke prevention after a transient ischemic attack (TIA).

Program chair previews HRS.19 highlights

The Heart Rhythm Society's 2019 scientific sessions will be held May 8-11 in San Francisco, a venue that enabled the program committee to tap into Silicon Valley’s expertise with digital health, emerging technology and innovation. HRS.19 Program Director Christine Albert, MD, MPH, gave Cardiovascular Business a preview of meeting highlights.

DOE transfers land to company targeting domestic Mo-99 production

The U.S. Department of Energy (DOE) has transferred 206 acres of land in Oak Ridge, Tennessee, to Coqui Radio Pharmaceuticals so the company can build a facility that domestically produces Molybdenum-99 (Mo-99), the most widely used isotope for nuclear imaging procedures.

Researchers propose new imaging biomarker for TIA, minor stroke

Quantifying a patient’s blood-brain barrier dysfunction (BBBD) could help inform risk stratification and stroke prevention strategies following a transient ischemic attack (TIA), researchers reported in the May edition of Stroke.

Researchers use deep learning, ECGs to detect hyperkalemia

A deep learning model trained on more than 1.5 million electrocardiograms can reliably detect hyperkalemia—or abnormally high potassium levels in the blood—among patients with chronic kidney disease (CKD), Mayo Clinic researchers reported April 3 in JAMA Cardiology.

AI reads x-rays to determine cardiac device manufacturer

An AI platform designed to quickly read an x-ray and determine the manufacturer and model of a cardiac rhythm device may quicken treatment in the event of device failure.

PET/MRI may uncover atherosclerosis at early stage

Hybrid PET/MRI revealed inflammation in plaque-free arterial segments in a sizable proportion of patients with subclinical atherosclerosis, suggesting the imaging technique may provide a lens into early stages of cardiovascular disease.

Ebit (Esaote Group) and DiA Imaging Analysis have partnered offering Advanced AI-based Cardiac Ultrasound Analysis

BE'ER SHEVA, Israel — Genoa, Italy — DiA Imaging Analysis, a leading provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that it has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo Cardiac Toolbox as an integrated part of Ebit's SUITESTENSA CVIS (Cardiovascular Information System) PACS.

Cardiac Imaging

AI-based coronary plaque evaluations highlight elevated heart risks in women

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Family of heart patient who died awarded $45M after suing health system for negligence

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

FDA clears catheter-based 4D visualization platform for complex heart procedures